Basic Information
ARTBIO is a radiopharmaceutical company. ARTBIO specializes in radioligand therapy, providing α or β emitters to break down cancer cell DNA and establishing an ecosystem to maximize therapeutic potential, enabling healthcare practitioners to implement new mechanisms in oncology.
ARTBIO, Inc.
The Kingdom of Norway
15~50 people
January 01, 2021
info@artbio.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios